A Single nucleotide polymorphism in 3' untranslated region of epithelial growth factor receptor confers risk for pulmonary hypertension in chronic obstructive pulmonary disease

Cellular Physiology and Biochemistry

Volumn 36, Issue 1, 2015, Pages 166-178

  Zhou, Sijing ^a,b   Li, Min ^b   Zeng, Daxiong ^c   Xu, Xuan ^d   Fei, Liming ^b   Zhu, Qingqing ^b   Zhang, Yan ^b   Wang, Ran ^b  

^a Hefei Center for Disease Control and Prevention   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

COPD; EGFR; MiR 214; PH; SNP

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA 214; 3' UNTRANSLATED REGION; CYTOSINE; EGFR PROTEIN, HUMAN; MICRORNA; MIRN124 MICRORNA, HUMAN; THYMINE;

3' UNTRANSLATED REGION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INVESTIGATIVE PROCEDURES; LUCIFERASE ASSAY; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN INTERACTION; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY; CELL CULTURE; COMPLICATION; CYTOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; PULMONARY ARTERY; SMOOTH MUSCLE FIBER; VERY ELDERLY;

3' UNTRANSLATED REGIONS; AGED; AGED, 80 AND OVER; CELLS, CULTURED; CYTOSINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; MALE; MICRORNAS; MYOCYTES, SMOOTH MUSCLE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTOR, EPIDERMAL GROWTH FACTOR; THYMINE;

EID: 84928751407     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374061     Document Type: Article

References (48)

1. Vestbo J, Hurd SS, Rodriguez-Roisin R: The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what? Clin Respir J 2012;6:208-214.
2. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X: Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-360.
3. Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J; Task Force: Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243-2278.
4. Wells A: EGF receptor. Int J Biochem Cell Biol 1999;31:637-643.
5. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW: Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003;284:31-53.
6. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC: Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001;3:802-808.
7. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL: The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 1990;65:1619-1625.
8. Wankel B, Schulze H: [Comprehensive review: veterinary medicine and wild animal research]. Dtsch Tierarztl Wochenschr 1976;83:383-386 contd.
9. Arteaga CL: The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 2001;19:32S-40S.
10. Merklinger SL, Jones PL, Martinez EC, Rabinovitch M: Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation 2005;112:423-431.
11. Dahal BK, Cornitescu T, Tretyn A, Pullamsetti SS, Kosanovic D, Dumitrascu R, Ghofrani HA, Weissmann N, Voswinckel R, Banat GA, Seeger W, Grimminger F, Schermuly RT: Role of epidermal growth factor inhibition in experimental pulmonary hypertension. Am J Respir Crit Care Med 2010;181:158-167.
12. Chu H, Wang M, Jin H, Lv Q, Wu D, Tong N, Ma L, Shi D, Zhong D, Fu G, Yuan L, Qin C, Yin C, Zhang Z: EGFR 3'UTR 774T>C polymorphism contributes to bladder cancer risk. Mutagenesis 2013;28:49-55.
13. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
14. Carthew RW: Gene regulation by microRNAs. Curr Opin Genet Dev 2006;16:203-208.
15. Pillai RS: MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005;11:1753-1761.
16. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM: MicroRNA expression and function in cancer. Trends Mol Med 2006;12:580-587.
17. Chen L, Li YS, Cui J, Ning JN, Wang GS, Qian GS, Lu KZ, Yi B: MiR-206 controls the phenotypic modulation of pulmonary arterial smooth muscle cells induced by serum from rats with hepatopulmonary syndrome by regulating the target gene, annexin A2. Cell Physiol Biochem 2014;34:1768-1779.
18. Wang R, Li M, Zhou SJ, Zeng DX, Xu X, Xu R, Sun GY: Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:463-473.
19. Saunders MA, Liang H, Li WH: Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 2007;104:3300-3305.
20. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M: A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006;38:813-818.
21. Georges M, Coppieters W, Charlier C: Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr Opin Genet Dev 2007;17:166-176.
22. Sethupathy P, Collins FS: MicroRNA target site polymorphisms and human disease. Trends Genet 2008;24:489-497.
23. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W: Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 2008;29:1306-1311.
24. Blitzblau RC, Weidhaas JB: MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk. Mol Diagn Ther 2010;14:335-342.
25. Weitzenblum E: Chronic cor pulmonale. Heart 2003;89:225-230.
26. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE: National Emphysema Treatment Trial (NETT) Group: Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002;166:314-322.
27. Weitzenblum E, Chaouat A: Severe pulmonary hypertension in COPD: is it a distinct disease? Chest 2005;127:1480-1482.
28. Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A: Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S-12S.
29. Ooi H, Cadogan E, Sweeney M, Howell K, O'Regan RG McLoughlin P: Chronic hypercapnia inhibits hypoxic pulmonary vascular remodeling. Am J Physiol Heart Circ Physiol 2000;278:H331-338.
30. Weissmann N, Manz D, Buchspies D, Keller S, Mehling T, Voswinckel R, Quanz K, Ghofrani HA, Schermuly RT, Fink L, Seeger W, Gassmann M, Grimminger F: Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia. Thromb Haemost 2005;94:630-638.
31. Wang R, Xu YJ, Liu XS, Zeng DX, Xiang M: Knockdown of connective tissue growth factor by plasmid-based short hairpin RNA prevented pulmonary vascular remodeling in cigarette smoke-exposed rats. Arch Biochem Biophys 2011;508:93-100.
32. Wang R, Xu YJ, Liu XS, Zeng DX, Xiang M: CCN2 promotes cigarette smoke-induced proliferation of rat pulmonary artery smooth muscle cells through upregulating cyclin D1 expression. J Cell Biochem 2012;113:349-359.
33. Wang R, Zhou SJ, Zeng DX, Xu R, Fei LM, Zhu QQ, Zhang Y, Sun GY: Plasmid-based short hairpin RNA against connective tissue growth factor attenuated monocrotaline-induced pulmonary vascular remodeling in rats. Gene Ther 2014;21:931-937.
34. Chen XM, Splinter PL, O'Hara SP, LaRusso NF: A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 2007;282:28929-28938.
35. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198.
36. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007;104:1604-1609.
37. Mann DL: MicroRNAs and the failing heart. N Engl J Med 2007;356:2644-2645.
38. Oglesby IK, McElvaney NG, Greene CM: MicroRNAs in inflammatory lung disease-master regulators or target practice? Respir Res 2010;11:148.
39. Jiang X: The emerging role of microRNAs in asthma. Mol Cell Biochem 2011;353:35-40,.
40. Courboulin A, Paulin R, Giguère NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Côté J, Simard MJ, Bonnet S: Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 2011;208:535-548.
41. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198.
42. Magrelli A, Azzalin G, Salvatore M, Viganotti M, Tosto F, Colombo T, Devito R, Di Masi A, Antoccia A, Lorenzetti S, Maranghi F, Mantovani A, Tanzarella C, Macino G, Taruscio D: Altered microRNA Expression Patterns in Hepatoblastoma Patients. Transl Oncol 2009;2:157-163.
43. Yang Z, Chen S, Luan X, Li Y, Liu M, Li X, Liu T, Tang H: MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 2009;61:1075-1082.
44. Salomon DS, Brandt R, Ciardiello F, Normanno N: Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995;19:183-232.
45. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70.
46. Mendelsohn J, Baselga J: The EGF receptor family as targets for cancer therapy. Oncogene 2000;19:6550-6565.
47. Chan AK, Kalmes A, Hawkins S, Daum G, Clowes AW: Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery. J Vasc Surg 2003;37:644-649.
48. Goldstein NI, Prewett M, Zuklys K, Rockwell P, Mendelsohn J: Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin Cancer Res 1995;1:1311-1318.